scispace - formally typeset
Search or ask a question
Institution

Centers for Disease Control and Prevention

GovernmentAtlanta, Georgia, United States
About: Centers for Disease Control and Prevention is a government organization based out in Atlanta, Georgia, United States. It is known for research contribution in the topics: Population & Public health. The organization has 58238 authors who have published 82592 publications receiving 4405701 citations. The organization is also known as: CDC & Centers for Disease Control and Prevention (CDC).


Papers
More filters
Journal ArticleDOI
18 Dec 2013-PLOS ONE
TL;DR: A 20-year-old HIV-positive adult on ART in the U.S. or Canada is expected to live into their early 70 s, a life expectancy approaching that of the general population.
Abstract: Background: Combination antiretroviral therapy (ART) has significantly increased survival among HIV-positive adults in the United States (U.S.) and Canada, but gains in life expectancy for this region have not been well characterized. We aim to estimate temporal changes in life expectancy among HIV-positive adults on ART from 2000–2007 in the U.S. and Canada.

1,182 citations

Journal ArticleDOI
TL;DR: Emerging infectious diseases, Emerging infectious diseases, کتابخانه دیجیتالی دانشگاه علوم پزش
Abstract: Emerging infectious diseases , Emerging infectious diseases , کتابخانه دیجیتالی دانشگاه علوم پزشکی و خدمات درمانی شهید بهشتی

1,182 citations

Journal ArticleDOI
TL;DR: Sexually transmitted infections are common in the United States, with a disproportionate burden among young adolescents and adults, and public health efforts should focus on prevention among at-risk populations to reduce the number and impact of STIs.
Abstract: BackgroundMost sexually active people will be infected with a sexually transmitted infection (STI) at some point in their lives. The number of STIs in the United States was previously estimated in 2000. We updated previous estimates to reflect the number of STIs for calendar year 2008.MethodsWe revi

1,179 citations

Journal ArticleDOI
TL;DR: This is, to the authors' knowledge, the first worldwide analysis of cancer survival, with standard quality-control procedures and identical analytic methods for all datasets, and should eventually facilitate joint assessment of international trends in incidence, survival, and mortality as indicators of cancer control.
Abstract: Summary Background Cancer survival varies widely between countries. The CONCORD study provides survival estimates for 1·9 million adults (aged 15–99 years) diagnosed with a first, primary, invasive cancer of the breast (women), colon, rectum, or prostate during 1990–94 and followed up to 1999, by use of individual tumour records from 101 population-based cancer registries in 31 countries on five continents. This is, to our knowledge, the first worldwide analysis of cancer survival, with standard quality-control procedures and identical analytic methods for all datasets. Methods To compensate for wide international differences in general population (background) mortality by age, sex, country, region, calendar period, and (in the USA) ethnic origin, we estimated relative survival, the ratio of survival noted in the patients with cancer, and the survival that would have been expected had they been subject only to the background mortality rates. 2800 life tables were constructed. Survival estimates were also adjusted for differences in the age structure of populations of patients with cancer. Findings Global variation in cancer survival was very wide. 5-year relative survival for breast, colorectal, and prostate cancer was generally higher in North America, Australia, Japan, and northern, western, and southern Europe, and lower in Algeria, Brazil, and eastern Europe. CONCORD has provided the first opportunity to estimate cancer survival in 11 states in USA covered by the National Program of Cancer Registries (NPCR), and the study covers 42% of the US population, four-fold more than previously available. Cancer survival in black men and women was systematically and substantially lower than in white men and women in all 16 states and six metropolitan areas included. Relative survival for all ethnicities combined was 2–4% lower in states covered by NPCR than in areas covered by the Surveillance Epidemiology and End Results (SEER) Program. Age-standardised relative survival by use of the appropriate race-specific and state-specific life tables was up to 2% lower for breast cancer and up to 5% lower for prostate cancer than with the census-derived national life tables used by the SEER Program. These differences in population coverage and analytical method have both contributed to the survival deficit noted between Europe and the USA, from which only SEER data have been available until now. Interpretation Until now, direct comparisons of cancer survival between high-income and low-income countries have not generally been available. The information provided here might therefore be a useful stimulus for change. The findings should eventually facilitate joint assessment of international trends in incidence, survival, and mortality as indicators of cancer control. Funding Centers for Disease Control and Prevention (Atlanta, GA, USA), Department of Health (London, UK), Cancer Research UK (London, UK).

1,178 citations


Authors

Showing all 58382 results

NameH-indexPapersCitations
Graham A. Colditz2611542256034
David J. Hunter2131836207050
Bernard Rosner1901162147661
Richard Peto183683231434
Aaron R. Folsom1811118134044
Didier Raoult1733267153016
James F. Sallis169825144836
David R. Jacobs1651262113892
Steven N. Blair165879132929
Gordon J. Freeman164579105193
Dennis R. Burton16468390959
Rory Collins162489193407
Ali H. Mokdad156634160599
Caroline S. Fox155599138951
Paul Elliott153773103839
Network Information
Related Institutions (5)
University of Maryland, Baltimore
64.7K papers, 2.9M citations

90% related

Emory University
122.4K papers, 6M citations

89% related

University of Alabama at Birmingham
86.7K papers, 3.9M citations

89% related

University of Colorado Denver
57.2K papers, 2.5M citations

89% related

University of North Carolina at Chapel Hill
185.3K papers, 9.9M citations

88% related

Performance
Metrics
No. of papers from the Institution in previous years
YearPapers
202327
2022254
20215,505
20205,426
20194,527
20184,344